ERK1/2 binding and phosphorylation stimulate the formation of TRAP1/SDH multimeric complex and enhance the inhibitory activity of TRAP1 on SDH (Masgras et al., 2017a), thereby positively contributing to the TRAP1-induced metabolic reprogramming of cancer cells. This evidence concerns the gene TRAP1 and cancer.